Company news
Jatt Ii Acquisition Corp (NASDAQ:JATT) news
Jatt Ii Acquisition Corp news releases on 6ix. Latest, Aug 27, 2026: JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
Press releases & updates
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
August 27, 2026
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
June 29, 2026
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
April 20, 2026
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
April 16, 2026
JATT Acquisition : INDEX TO CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K
April 6, 2023
JATT Acquisition : SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
March 24, 2023
JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited
March 15, 2023
JATT Acquisition Corp Announces Planned Transfer of Listing to NASDAQ in Connection with its Proposed Business Combination with Zura Bio Limited
March 12, 2023
JATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SEC
March 2, 2023
JATT Acquisition Corp. and Zura Bio Limited Announce Definitive Business Combination Agreement to Create NYSE Listed Biotechnology Company
June 16, 2022